Eurofins stock completes two portfolio deals in October

Published on 10/05/2026 at 22:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eurofins stock carries a EUR 575 million divestment and a USD 400 million acquisition dated October 2, 2026. H1 2026 adjusted EBITDA margin rose 130 basis points to 23.7 percent.

Isometrische Infografik einer Testprozesskette von Probenahme bis Datenauswertung — Isometrische 3D-Darstellung der Testprozesskette zeigt die Wertschöpfung von Eurofins Scientific SE, ISIN FR0014000MR3, im Labor, Illustration mit AI erstellt.

Eurofins stock completed two portfolio deals in October, while the shares were last at EUR 75.54 on Euronext Paris on October 5, 2026 at 5:35 p.m. CEST. The company completed a EUR 575 million divestment and a USD 400 million acquisition on October 2, giving investors a sharper view of its portfolio reshaping.

Two deals reshape the portfolio

According to Eurofins on October 2, 2026, the group completed its acquisition of Element Materials Technology's Life Sciences Testing Services business in North America for an enterprise value of USD 400 million.

The same Eurofins release states that the company completed the divestment of its Electrical and Electronic Testing business to UL Solutions for an enterprise value of EUR 575 million on October 1, 2026. The transactions point to a capital-allocation strategy that shifts the portfolio toward core life science testing while transferring MET Labs to a new owner.

H1 margin gains support the strategy

Eurofins reported its H1 2026 results on July 23, 2026. Its adjusted EBITDA margin expanded 130 basis points year over year to 23.7 percent, and adjusted earnings per share increased 29 percent to EUR 1.55, according to Yahoo Finance.

That margin figure places the group near its FY 2027 adjusted EBITDA margin objective of 24 percent, which Eurofins lists on its investor page. The comparison matters because the deal activity is being paired with operating improvement rather than presented as a standalone acquisition story.

Analyst target sits above the price

Ideal Investisseur reported on October 2, 2026 that CIC Market Solutions rated Eurofins Buy with an EUR 80 price target, while the published median target was EUR 73.90. At EUR 75.54, the EUR 80 target lies 5.90 percent above the price, whereas the median target lies 2.17 percent below it.

The market view is therefore divided between a named Buy target and a median below the latest quote. Eurofins also lists investor events in Amersfoort on October 23, 2026 and Toronto on November 11, 2026, keeping portfolio execution and operating leverage on the calendar.

Eurofins stock stays below yearly high

Eurofins stock was last at EUR 75.54 on Euronext Paris on October 5, 2026, with a session change of 0.91 percent. The price stood 4.65 percent below the 52-week high of EUR 79.22 and above the 52-week low of EUR 54.86, while volume reached 412,968 shares.